Embecta Corp has a consensus price target of $12.67, established from looking at the 13 latest analyst ratings. The last 3 analyst ratings were released from Morgan Stanley, Morgan Stanley, and Morgan Stanley on May 10, 2024, November 22, 2023, and October 18, 2023. With an average price target of $14.67 between Morgan Stanley, Morgan Stanley, and Morgan Stanley, there's an implied 1.50% upside for Embecta Corp from these 3 analyst ratings.
1calculated from analyst ratings published within the last 3 years
Buy Now | Get Alert | |||||||
---|---|---|---|---|---|---|---|---|
05/10/2024 | Buy Now | -10.03% | Morgan Stanley | Cecilia Furlong | $16 → $13 | Maintains | Underweight | Get Alert |
11/22/2023 | Buy Now | 10.73% | Morgan Stanley | Cecilia Furlong | $15 → $16 | Maintains | Underweight | Get Alert |
10/18/2023 | Buy Now | 3.81% | Morgan Stanley | Cecilia Furlong | $16 → $15 | Maintains | Underweight | Get Alert |
08/24/2023 | Buy Now | 10.73% | Morgan Stanley | Cecilia Furlong | $19 → $16 | Maintains | Underweight | Get Alert |
07/18/2023 | Buy Now | 31.49% | Morgan Stanley | Cecilia Furlong | $29 → $19 | Maintains | Underweight | Get Alert |
05/15/2023 | Buy Now | 100.69% | Morgan Stanley | Cecilia Furlong | $28 → $29 | Maintains | Underweight | Get Alert |
01/06/2023 | Buy Now | 93.77% | Morgan Stanley | Cecilia Furlong | → $28 | Downgrade | Equal-Weight → Underweight | Get Alert |
12/21/2022 | Buy Now | 114.53% | Morgan Stanley | Cecilia Furlong | $33 → $31 | Maintains | Equal-Weight | Get Alert |
10/11/2022 | Buy Now | 128.37% | Morgan Stanley | Cecilia Furlong | $36 → $33 | Maintains | Equal-Weight | Get Alert |
09/08/2022 | Buy Now | — | BTIG | Marie Thibault | — | Initiates | → Neutral | Get Alert |
08/16/2022 | Buy Now | 149.13% | Morgan Stanley | Cecilia Furlong | $33 → $36 | Maintains | Equal-Weight | Get Alert |
08/01/2022 | Buy Now | 128.37% | Morgan Stanley | Cecilia Furlong | → $33 | Initiates | → Equal-Weight | Get Alert |
06/21/2022 | Buy Now | 73.01% | B of A Securities | Travis Steed | → $25 | Initiates | → Underperform | Get Alert |
The latest price target for Embecta (NASDAQ: EMBC) was reported by Morgan Stanley on May 10, 2024. The analyst firm set a price target for $13.00 expecting EMBC to fall to within 12 months (a possible -10.03% downside). 5 analyst firms have reported ratings in the last year.
The latest analyst rating for Embecta (NASDAQ: EMBC) was provided by Morgan Stanley, and Embecta maintained their underweight rating.
There is no last upgrade for Embecta.
The last downgrade for Embecta Corp happened on January 6, 2023 when Morgan Stanley changed their price target from N/A to $28 for Embecta Corp.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Embecta, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Embecta was filed on May 10, 2024 so you should expect the next rating to be made available sometime around May 10, 2025.
While ratings are subjective and will change, the latest Embecta (EMBC) rating was a maintained with a price target of $16.00 to $13.00. The current price Embecta (EMBC) is trading at is $14.45, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.